skip to main content
Show Results with:

Results 1 - 10 of 20  for Everything in this catalogue

results 1 2 next page
Refined by: subject: Electronic journals remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Material Type:
Article
Add to My workspace

Multidisciplinary treatment of lung cancer in older patients: A review

Radovic, Marco et al.

Journal of geriatric oncology. Volume 10:Number 3 (2019, May); pp 405-410 -- Elsevier Ltd

Online access

2
Material Type:
Article
Add to My workspace

Multidisciplinary treatment of lung cancer in older patients: A review

Radovic, Marco et al.

Journal of geriatric oncology. Volume 10:Issue 3 (2019); pp 405-410 -- Elsevier Ltd

Online access

3
Material Type:
Article
Add to My workspace

Multicenter Phase II Study of Panitumumab in Platinum Pretreated, Advanced Head and Neck Squamous Cell Cancer

Siano, Marco et al.

The oncologist. Volume 22:Number 7 (2017, July); pp 782-e70 -- AlphaMed Press

Online access

4
Material Type:
Article
Add to My workspace

Multicenter Phase II Study of Panitumumab in Platinum Pretreated, Advanced Head and Neck Squamous Cell Cancer

Siano, Marco et al.

The oncologist. Volume 22:Number 7 (2017, July); pp 782-e70 -- AlphaMed Press

Online access

5
Material Type:
Article
Add to My workspace

Multicenter Phase II Study of Panitumumab in Platinum Pretreated, Advanced Head and Neck Squamous Cell Cancer

Siano, Marco et al.

The oncologist. Volume 22:Number 7 (2017, July); pp 782-e70 -- AlphaMed Press

Online access

6
Material Type:
Article
Add to My workspace

Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab

Diem, Stefan et al.

Lung cancer. Volume 111 (2017); pp 176-181 -- Elsevier Science Pub. Co

Online access

7
Material Type:
Article
Add to My workspace

Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab

Diem, Stefan et al.

Lung cancer. Volume 111: (2017, September); pp 176-181 -- Elsevier Science Pub. Co

Online access

8
Material Type:
Article
Add to My workspace

Human leukocyte antigen variation is associated with adverse events of checkpoint inhibitors

Hasan Ali, Omar et al.

European journal of cancer. Volume 107 (2019); pp 8-14 -- Elsevier

Online access

9
Material Type:
Article
Add to My workspace

Human leukocyte antigen variation is associated with adverse events of checkpoint inhibitors

Hasan Ali, Omar et al.

European journal of cancer. Volume 107: (2019, January); pp 8-14 -- Elsevier

Online access

10
Material Type:
Article
Add to My workspace

Role of Cytochrome P450 3A4 and 1A2 Phenotyping in Patients with Advanced Non‐small‐Cell Lung Cancer Receiving Erlotinib Treatment

Parra‐Guillen, Zinnia P. et al.

Basic & clinical pharmacology & toxicology. Volume 121:Issue 4 (2017); pp 309-315 -- John Wiley & Sons, Ltd

Online access

Results 1 - 10 of 20  for Everything in this catalogue

results 1 2 next page

Refine Search Results

Refine my results

Access Options 

  1. Request to Reading Room  (18)
  2. Online: Reading Room only  (13)
  3. Purchase a copy  (7)
  4. Refine further open sub menu

Creation date 

From To

Additional Features 

  1. Abstract  (18)
  2. No Abstract  (2)
  3. Refine further open sub menu

Searching Remote Databases, Please Wait